Insights

Asia Expansion Amai Proteins has repeatedly expanded its offices into Asia, with recent and ongoing regulatory footprint growth in Singapore. This indicates strong regional growth plans and a ready market for food ingredients in Asian markets, presenting opportunities to engage regional distributors, food manufacturers, and regulators for Sweelin adoption.

Regulatory Readiness Sweelin is approved in Singapore and expanding regulatory footing across Asia, signaling a favorable regulatory environment for new sweet protein applications. This creates opening for partnerships with food formulators seeking clean-label sugar reductions and stability across diverse beverage and condiment portfolios.

Product Readiness The company has a scalable sweet protein platform with high sweetness intensity and stability, suitable for Ketchup, beverages, and other processed foods. This enables targeted outreach to customers in sauces, dairy alternatives, and reduced-sugar product lines seeking taste-compatible sugar reduction.

Strategic Partnerships Past collaborations with Ocean Spray and a notable funding round underscore active interest from consumer goods brands and investors in protein-based sweeteners. This suggests a channel for co-development agreements, pilot programs, and potential distribution or licensing deals with CPG manufacturers.

Financial and Growth Signals Revenue range and recent funding indicate a startup poised for rapid scale, with opportunities to target mid-market food & beverage brands looking to accelerate sugar reduction initiatives. Consider offering pilot collaborations, technical support, and regulatory-assist services to accelerate adoption.

Similar companies to Amai Proteins

Amai Proteins Tech Stack

Amai Proteins uses 8 technology products and services including Calendly, GitHub, cdnjs, and more. Explore Amai Proteins's tech stack below.

Media & News

Amai Proteins's Email Address Formats

Amai Proteins uses at least 1 email format:
Amai Proteins Email FormatsExamplePercentage
First.Last@amaiproteins.comJohn.Doe@amaiproteins.com
100%

Frequently Asked Questions

What is Amai Proteins's official website and social media links?

Minus sign iconPlus sign icon
Amai Proteins's official website is amaiproteins.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Amai Proteins generate?

Minus sign iconPlus sign icon
As of October 2026, Amai Proteins's annual revenue is estimated to be $10M - $25M.

What is Amai Proteins's SIC code and NAICS code?

Minus sign iconPlus sign icon
Amai Proteins's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amai Proteins have currently?

Minus sign iconPlus sign icon
As of October 2026, Amai Proteins has approximately 50 employees across 3 continents, including Asia, North America and Europe. Key team members include Chief Executive Officer: A. G., Chief Marketing Officer: W. C. and Chief Financial Officer: M. H. Explore Amai Proteins's employee directory with LeadIQ.

What industry does Amai Proteins belong to?

Minus sign iconPlus sign icon
Amai Proteins operates in the Biotechnology Research industry.

What technology does Amai Proteins use?

Minus sign iconPlus sign icon
Amai Proteins's tech stack includes Calendly, GitHub, cdnjs, Wix, WordPress, Shopify, Microsoft 365 and Google Cloud.

What is Amai Proteins's email format?

Minus sign iconPlus sign icon
Amai Proteins's email format typically follows the pattern of First.Last@amaiproteins.com. Find more Amai Proteins email formats with LeadIQ.

How much funding has Amai Proteins raised to date?

Minus sign iconPlus sign icon
As of October 2026, Amai Proteins has raised $23M in funding. The last funding round occurred on Dec 04, 2022 for $9.1M.

When was Amai Proteins founded?

Minus sign iconPlus sign icon
Amai Proteins was founded in 2016.
Amai Proteins logo

Amai Proteins

Biotechnology ResearchCentral District, Israel11-50 Employees

Amai Proteins is a biotechnology research company based in Rehovot, Israel, focused on creating novel proteins for consumer and industrial uses. Its initial offering centers on a designer sweet protein derived from natural inspiration and produced through fermentation, aimed at food and beverage applications. The company leverages a platform it calls pro-protein to enable new breakthroughs in protein design and production.

Its customers span both individual consumers and food and beverage manufacturers seeking alternatives to conventional ingredients. In recent developments, Amai expanded its presence in Asia and gained regulatory approval for its Sweelin sweet protein as a food additive in Singapore, broadening its footprint in the region.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $23M

    Amai Proteins has raised a total of $23M of funding over 7 rounds. Their latest funding round was raised on Dec 04, 2022 in the amount of $9.1M as a Venture Round.

  • $10M - $25M

    Amai Proteins's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.